Novel Agent Set for Unique Clinical Test in Inflammatory Breast Cancer
Tuesday, December 10, 2013 - 17:00
in Health & Medicine
A drug now used to treat a type of lymphoma has shown surprising benefit in preclinical studies of inflammatory breast cancer